Pinned Tweet
Thrilled to share that our abstract has been accepted for a Moderated Digital Poster presentation at the American Heart Association (AHA) Scientific Sessions 2026 in Chicago! 🫀🎉
I’m incredibly grateful to my mentors, collaborators, and co-authors for their guidance, support, and contributions throughout this work.
Looking forward to presenting our findings, learning from the latest cardiovascular research, and connecting with colleagues from around the world at #AHA2026 this November!
See you in Chicago! 🇺🇸❤️
#AHAScientificSessions #AHA2026 #Cardiology #CardiovascularResearch #Research #MedicalResearch
Had a great time at the AHA Scientific Sessions 2026. Really enjoyed the opportunity to present our research, connect with others in the field, and learn about the latest research and advances in cardiovascular care. It was a great experience, and I’m grateful to have been part of it.
doi.org/10.1161/circ.154.sup…
1
51
Spent the day at Mount Sinai for ECHO NY: Structural Heart Disease Imaging
Great talks and discussions on echocardiography, valvular heart disease, and the latest approaches to structural heart care. Always good to learn something new and hear from experts in the field!
#Echocardiography #Cardiology #StructuralHeartDisease #MountSinai
4
116
jacc.org/doi/10.1016/j.jacc.…
🫀 PARTNER 3 | 7-Year Health Status Outcomes
In low-risk severe aortic stenosis, both TAVR (SAPIEN 3) and SAVR provided durable improvements in quality of life through 7 years.
🔹 TAVR offered markedly faster early recovery
🔹 Differences diminished by 6 months
🔹 No significant differences beyond 2 years
#TAVR #SAVR #PARTNER3 #JACC
1
123
TRIC-I-HF: Beyond symptom relief.
In patients with severe TR and advanced HF, transcatheter tricuspid repair + medical therapy improved 1-year clinical outcomes and reduced death/HF hospitalization through longer follow-up versus medical therapy alone.
An important step forward for T-TEER.
#StructuralHeart #HeartFailure
nejm.org/doi/full/10.1056/NE…
1
106
🫀 Can AI predict heart failure before it develops?
A new study in JACC: Heart Failure suggests that AI analysis of echocardiograms can identify patients who may develop heart failure in the future.
🔍 A promising step toward earlier risk detection and prevention—but prospective validation is essential.
#AI #Cardiology #HeartFailure #Echo
doi.org/10.1016/j.jchf.2026.…
1
1
114
🫀 Promising, but not definitive!
In a small sham-controlled pilot of Synchronized Diaphragmatic Stimulation (SDS):
✅ Implantation feasible
✅ No procedure-, device-, or therapy-related adverse events through 12 months
📈 Favorable signals in 6MWD & quality of life
❌ Primary LVESV endpoint NOT met
🔎 Larger trials needed to confirm efficacy.
doi.org/10.1016/j.jchf.2026.…
1
50
AI is transforming cardiovascular imaging, from automating measurements to providing real-time clinical guidance.
cardioserv.net/artificial-in…
1
70
Aladin Altic retweeted
FROM A SIMPLE TUBE TO A FOUR-CHAMBERED HEART
Cardiac development is a coordinated sequence of growth, looping and septation.
🟨 Week 3: The first and second heart fields form the early cardiac progenitors.
🟩 Week 4: The primitive heart tube forms and begins rightward (dextral) looping, establishing the basic spatial arrangement of the future heart.
🟦 Weeks 4-5: Chamber formation occurs through localized myocardial growth and ballooning. The outflow tract lengthens and moves between the developing atria.
🟪 Weeks 5-7: Atrial septation develops through the septum primum, septum secundum and endocardial cushion complex.
🟥 Weeks 6-8: The outflow tract undergoes rotation and septation, separating the future aortic and pulmonary pathways.
By the end of the 8th week, the basic anatomical plan of the heart is established, although maturation continues throughout fetal life.
Reference: Braunwald’s Heart Disease, chapter on congenital heart disease and cardiac development.
Aladin Altic retweeted
Decompensated HF: High-Yield Numbers to Memorize
The 2026 ESC Guidelines contain several important thresholds:
1️⃣ SpO₂ <90% or PaO₂ <60 mmHg: oxygen therapy
2️⃣ RR >25/min + SpO₂ <90% + respiratory distress: consider NIV
3️⃣ uNa⁺ ≥70 mEq/L at 2 h: satisfactory diuretic response
4️⃣ Urine output ≥100 mL/h during the first 6 h: satisfactory response
5️⃣ SBP >110 mmHg: IV vasodilators may be considered
6️⃣ SBP <90 mmHg + hypoperfusion despite standard treatment: inotropes may be considered
7️⃣ 40 mg IV furosemide: usual starting dose in diuretic-naïve patients
8️⃣ 2× usual oral loop-diuretic dose: consider when already taking loop diuretics
9️⃣ After initial stabilization: initiate an SGLT2 inhibitor in hospital
Quick memory:
90: oxygen threshold
70: urinary sodium
100: urine output
110: vasodilator threshold
Based on the 2026 ESC Guidelines for the management of heart failure.
Our new paper is out! 🫀
We review coronary microvascular dysfunction in ANOCA/INOCA, from pathophysiology and diagnosis to coronary function testing and mechanism-based, individualized treatment.
mdpi.com/1873-149X/33/4/73
6
130
Important perspective in JACC on rethinking disease progression in ATTR-CM.
As therapies become increasingly mechanism-specific, monitoring needs to evolve beyond downstream clinical markers toward the biology being targeted: TTR precursor biology, amyloid burden, and organ response.
A framework that could help move ATTR-CM closer to truly personalized, mechanism-guided care.
jacc.org/doi/10.1016/j.jacc.…
1
91
In patients with cancer, obstructive sleep apnea was associated with a higher risk of cardiovascular events, particularly heart failure and atrial fibrillation/flutter. These findings highlight the potential importance of recognizing and managing OSA as part of cardiovascular risk assessment in cancer care.
ahajournals.org/doi/10.1161/…~
1
86
A lower gradient may not tell the whole story after TAVR.
4D-flow CMR may offer a new way to assess success: are we actually restoring physiological aortic flow?
Could flow restoration become the next marker of TAV performance?
ahajournals.org/doi/10.1161/…
2
117
Important new data in ATTR-CM: sinus rhythm ≠ low stroke risk.
Among patients with ATTR-CM in sinus rhythm, atrial electromechanical dissociation was associated with ~3× higher risk of stroke/TIA, while severely impaired LA contraction identified an even higher-risk group.
LA strain may add an important layer to stroke risk assessment beyond rhythm and CHA₂DS₂-VASc.
jacc.org/doi/10.1016/j.jacc.…
1
108
New CARDIO-TTRansform analysis: eplontersen showed benefit in ATTR-CM patients not on baseline TTR stabilizers (RR 0.71), but no demonstrated added benefit in those already on stabilizer therapy (RR 1.14). Important caveat: the overall trial missed its primary endpoint, so subgroup findings are hypothesis-generating.
nature.com/articles/s41591-0…~
2
95
Important new data on leadless pacemaker safety: adverse-event reports increased annually from 2021–2024, with concerns about serious injury, malfunction, death, and the accuracy/completeness of postmarket reporting. Greater transparency in surveillance data is needed.
ahajournals.org/doi/10.1161/…
2
94
Aladin Altic retweeted
Watch the mitral valve carefully during systole.
What is the most likely diagnosis?
A. Mitral stenosis
B. Mitral valve prolapse
C. Mitral annular calcification
D. Flail mitral leaflet
Happy to share our new paper: “Endothelial Injury as a Potential Contributor to Cardiovascular Toxicity in Hematologic Malignancies.”
Grateful to my co-authors for their contributions and collaboration.
mdpi.com/2079-9721/14/9/342
Aladin Altic retweeted
Tale as old as time. Lasix nephrotoxicity: the Bigfoot of inpatient medicine. Too many fear it. Nobody’s actually seen it.
Meanwhile the kidneys are drowning in venous congestion wondering why nobody will just give the F* Lasix. LASIX IS NOT NEPHROTOXIC. CIN doesn’t exist. @ASNKidney we need your help to say “Bigfoot” is just AI.
ahajournals.org/doi/10.1161/…
LUMINARA, a Phase 2b, international, multicenter, randomized, double-blind, placebo-controlled trial, evaluated the oral RXFP1 agonist AZD5462 in 375 patients with chronic heart failure. AZD5462 was well tolerated and showed encouraging effects on cardiovascular hemodynamics, supporting larger outcomes trials. #HeartFailure #Cardiology #LUMINARA
3
119











